NCT07882862: HRT-PC Trial: Hormone Recovery After Treatment for Prostate Cancer Trial. An Open-label Phase II Study of Clomiphene Citrate in Patients With Persistent Hypogonadism After ADT for Treatment of Localized Prostate Cancer
- State
- Not started
- Phase
- Phase 2
- People
- 83 planned
- Started
- 31 Jan 2027
- Primary completion
- 30 Jun 2029
- Arms
- Cohort A - oral clomiphene citrate, 25 mg, once daily for 6 months
- Results
- None posted
- 20 Oct 2026: Trial registered